mdlinx mdlinx

Pharma News Journals | Online Pharma News Journals

This MDLinx specialty site works from a list of pharma news journals judged by our physician readers to be the most important sources of articles for practicing physicians.

Every 24 hours:

  • The entire pharma news journal list is electronically scanned to identify any newly-appearing articles.
  • The editors scour the new pharma news articles, sorting each article for the appropriate specialties and subspecialty topic distribution.
  • Each article is briefly summarized to help you determine if you want to retrieve the abstract or article from the publishers website or your library.
  • Research articles are summarized in an extended format that allows you to quickly determine the nature, quality, and outcomes of the study.
  • Our goal is to publish all the new articles to the site and email distribution within 24 to 48 hours.

MDLinx exists because of the readership of our physicians and the fees paid by our advertisers. Advertising sales and placement are completely independent of our editorial efforts. Editors are directed to serve the needs of you the reader. That's our mission.

Click journal name to leave the MDLinx Network and go to the Journal's Website

AAIPharma

ABN Newswire

APP Pharmaceuticals - Fresenius Kabi USA

ARIAD Pharmaceuticals

Abbott

Acacia Pharma

Actavis

Active Biotech

Agenus

Alcon

Allos Therapeutics

Amgen

Amicus Therapeutics

Anesiva

Angiotech Pharmaceuticals

Applied Clinical Trials

Aptalis

Arbor Pharmaceuticals

Array BioPharma

Astellas

AstraZeneca

B3C newswire

BTG

Baxter

Bayer HealthCare Pharmaceuticals

BioMarin

BioMimetic Therapeutics

BioPharm International

Biogen Idec

Biophage Pharma

Biota

Boehringer Ingelheim

Boston Scientific

Bristol Myers-Squibb

Business Wire - Health Wire

CEL-SCI

Cardinal Health

Cell Therapeutics

Chugai Pharmaceutical Co.

Cogent Neuroscience

Corporate News Releases - The Healthcare Sales & Marketing Network

Covidien

CryoLife

Cytokinetics

Daiichi Sankyo

Dendreon Coproration

Destiny Pharma

Draxis

Elan

Enzon Pharmaceuticals

EyeGate Pharma

Forest Laboratories

Galderma

Gene-Cell

Genentech

Genetronics, Inc.

Genmab

Genzyme

Gilead

GlaxoSmithKline

Hill & Knowlton

ImmunoGen, Inc.

Janssen

Johnson & Johnson

Lundbeck

Lynx

MedImmune

MediGene

Medicis

Medtronic

Merck

Merck Serono

Millennium Pharmaceuticals

Morphotek

Mpex Pharmaceuticals

Mylan

Myriad Genetics

NPS Pharmaceuticals

Nature

Nephros

New England Journal of Medicine

Nordion

Novartis

Onyx Pharmaceuticals

Orexigen Therapeutics

Ovid Technologies

Oxford Glycosciences PLC

PRNewswire

Par Pharmaceutical

Patheon

Pfizer

PhRMA

Pharmaceutical Executive Magazine

PharmiWeb

Plexxikon

Purdue Pharma

Quintiles Transnational

Repligen

Roche

SLIL Biomedical Corp.

Salix Pharmaceuticals

Sanofi

Sarepta Therapeutics

Shire

Sophiris Bio

Spherix

Sunovion

Synosia Therapeutics

Synthon

TAP Pharmaceutical

Takeda Pharmaceuticals U.S.A.

Taro Pharmaceuticals USA

Teva Pharmaceutical Industries

The Lancet

UCB

Valeant Pharmaceuticals International

Warner Chilcott

XenoPort

Yamanouchi Pharmaceutical

Zila

deCODE genetics

diaDexus


Recommend changes to our editors at content@mdlinx.com

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close